Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.
Bertheau P, Turpin E, Rickman DS, Espié M, de Reyniès A, Feugeas JP, Plassa LF, Soliman H, Varna M, de Roquancourt A, Lehmann-Che J, Beuzard Y, Marty M, Misset JL, Janin A, de Thé H. Bertheau P, et al. Among authors: turpin e. PLoS Med. 2007 Mar;4(3):e90. doi: 10.1371/journal.pmed.0040090. PLoS Med. 2007. PMID: 17388661 Free PMC article.
TP53 status and response to chemotherapy in breast cancer.
Bertheau P, Espié M, Turpin E, Lehmann J, Plassa LF, Varna M, Janin A, de Thé H. Bertheau P, et al. Among authors: turpin e. Pathobiology. 2008;75(2):132-9. doi: 10.1159/000123851. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544968 Free article. Review.
p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors.
Varna M, Lehmann-Che J, Turpin E, Marangoni E, El-Bouchtaoui M, Jeanne M, Grigoriu C, Ratajczak P, Leboeuf C, Plassa LF, Ferreira I, Poupon MF, Janin A, de Thé H, Bertheau P. Varna M, et al. Among authors: turpin e. Int J Cancer. 2009 Feb 15;124(4):991-7. doi: 10.1002/ijc.24049. Int J Cancer. 2009. PMID: 19048622 Free article.
Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.
Lehmann-Che J, André F, Desmedt C, Mazouni C, Giacchetti S, Turpin E, Espié M, Plassa LF, Marty M, Bertheau P, Sotiriou C, Piccart M, Symmans WF, Pusztai L, de Thé H. Lehmann-Che J, et al. Among authors: turpin e. Oncologist. 2010;15(3):246-52. doi: 10.1634/theoncologist.2009-0243. Epub 2010 Mar 12. Oncologist. 2010. PMID: 20228131 Free PMC article. Clinical Trial.
p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P, Lehmann-Che J, Varna M, Dumay A, Poirot B, Porcher R, Turpin E, Plassa LF, de Roquancourt A, Bourstyn E, de Cremoux P, Janin A, Giacchetti S, Espié M, de Thé H. Bertheau P, et al. Among authors: turpin e. Breast. 2013 Aug;22 Suppl 2:S27-9. doi: 10.1016/j.breast.2013.07.005. Breast. 2013. PMID: 24074787 Free article. Review.
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy.
Varna M, Soliman H, Feugeas JP, Turpin E, Chapelin D, Legrès L, Plassa LF, de Roquancourt A, Espié M, Misset JL, Janin A, de Thé H, Bertheau P. Varna M, et al. Among authors: turpin e. Br J Cancer. 2007 Oct 22;97(8):1157-64. doi: 10.1038/sj.bjc.6603937. Epub 2007 Sep 18. Br J Cancer. 2007. PMID: 17876337 Free PMC article.
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.
Lehmann-Che J, Amira-Bouhidel F, Turpin E, Antoine M, Soliman H, Legres L, Bocquet C, Bernoud R, Flandre E, Varna M, de Roquancourt A, Plassa LF, Giacchetti S, Espié M, de Bazelaire C, Cahen-Doidy L, Bourstyn E, Janin A, de Thé H, Bertheau P. Lehmann-Che J, et al. Among authors: turpin e. Br J Cancer. 2011 May 24;104(11):1739-46. doi: 10.1038/bjc.2011.135. Epub 2011 May 3. Br J Cancer. 2011. PMID: 21540864 Free PMC article.
65 results